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During the last two decades, the concept and understanding of the cytosoiic
1 2and the plasma membrane have emerged. ’ The importance of the antigenicity of
the glycoprotein and glycolipid - A, B, O - blood group substances were appreciated
long before membrane receptors became a topic of extensive research. There is
increasing evidence that most plasma membrane receptors such as the hormone
receptors for insulin, glycagon, adrenocorticotrophic hormone, epinephrine and
3
norepinephrine are glycoproteins. A glycoprotein is defined as a macromolecule
which contains a protein portion to which is attached specific carbohydrate
structures.
Adrenergic and cholinergic receptors are present in nerve, and in cardiac,
skeletal and smooth muscle tissue. These receptors participate in a variety of
3
neuronal, neuromuscular and muscular activities. The acetylcholine receptors on
the post-synaptic side of the neuromuscular junction in man, rabbit, and some
aquatic organisms have been shown to be glycoproteins which, when injected into
If.
other species, are highly immunogenic.
Some diseases of the central nervous system and of muscle are classified as
5-7
autoimmune diseases. An autoimmune, disease is one in which the immune system
of the host fails to recognize an indigenous substance (usually a macromolecule) as
g
'self and thereby produces antibodies to this substance in order to facilitate its
2
9removal from the body by deactivation and if necessary by phagocytosis. Acetyl¬
choline receptor has been shown by Lindstrom and Patrick^® to be the antigenic
substance against which the immune system of the patient with Myasthenia gravis
(MG) directs antibody production. Thus, MG, a crippling neuromuscular disease, is
classified as an autoimmune disease. Early studies on the immunological
properties of the AcChR from tiie electric organ of Electrophorus electricus (eel)
led to the development of an animal model for
In order to provide a background against which the abnormality of MG may be
understood, it is necessary to review the normal structure and function of the
neuromuscular junction. In normal muscle contraction, acetylcholine which is
released from the pre-synaptic nerve ending at the muscle end-plate reacts with
specific receptor molecules of the muscle resulting in an increase in membrane
2 13
permeability to cations. ’ This change in permeability is thought to be mediated
2 a 13
by a minimum of two distinct structural features: * ’ a 'receptor* protein which
recognizes acetylcholine or cholinergic agonists and an 'ionophore' that accounts for
the selective permeability of the membrane to ions. When the motor neurons
contact the muscle at the motor end-plate, they (the neurons) lose their myelin and
the terminal expansion of their axons interdigitate the muscle. At an ultrastructural
level, many small vesicles can be seen, in the neuroterminai expansion (Appendix I).
These vesicles contain acetylcholine which is released upon stimulation of the nerve.
The released acetylcholine crosses the synaptic cleft between the nerve and muscle.
Acetylcholine reacts with the receptor of the post-synaptic membrane causing a
depolarization at the end-plate region great enough to be detected experimentally as
a miniature end-plate potential. The resultant propagated electrical potential leads
3
to contraction of the muscle fiber. The acetylcholine is then hydrolyzed by
acetylcholinesterase. Repolarization of the motor nerve will occur after stimulation
has ceased and repolarization of the muscle will occur when the acetylcholine has
been hydrolyzed.
In MG the motor nerve endings in the musles of patients are structually
14 15
unaltered, contain normal amounts of acetylcholine, and the quantal release of
acetylcholine is normal in response to nerve impulses. The post-synaptic
membrane of the muscle is, however, less sensitive to acetylcholine,^^ simplified in
14 14
structure, reduced in area, and contains reduced numbers of acetylcholine
18
receptor molecules, many of which are bound by antibody. Because a large
fraction of the decreased number of AcChR is inactivated by antibody, the normal
response to acetylcholine is further reduced. The antigenicity of the AcChR
purified from Torpedo californica (string ray) is significantiy decreased following
19
proteinase treatment. Similarly, urea treatment of the AcChR also results in the
12loss of antigenicity. These results suggest that the protein moiety of the AcChR
plays an important role in the antigenicity of this receptor. It is possible that
alteration of the protein component by proteinase or by urea may result in a change
in the spatial arrangement of the covalently attached carbohydrate component and,
hence, decrease the ability of this chemical group to react with antibodies. The
foregoing experiments do not address the problem of whether the carbohydrate
constituent is also antigenic.
This study centers on the antigenicity of the carbohydrate and protein moieties
of the AcChR purified from rabbit skeletal muscle. Antigenicity was tested using
sera of MG patients. The results corroborated the earlier findings that the protein
4
portion is antigenic and present new evidence to suggest that the carbohydrate
moiety of the native and denatured AcChR is also antigenic.
EXPERIMENTAL
Agarose, bovine serum albumin (BSA), Con A from Canavalia ensiformis. Con
A-Sepharose 4B, diethylaminoetyl (DEAE) cellulose, Garden Pea lectin from Pisum
sativum, pronase type VIII, pronase type XI, pronase type XIV, Sephadex G-200-120,
Sepharose 4B, sodium m-periodate, soybean lectin from Glycin Max, triphenyl
tetrazolium chloride (TTC), Tris (hydroxymethyl) aminomethane hydrochloride (Tri-
HCl) and all carbohydrates were purchased from the Sigma Chemical Company (St.
Louis, Missouri). Eastman 13179 silica gel paper (20 x 29 cm) and Whatman No. 3
chromatography (46 x 57 cm) were purchased from Fisher Scientific Company
(Norcross, Georgia). Triton X-100 was purchased from Rohm and Haas Company
(Philadelphia, Pennsylvania). Petri dishes (box type, 100 x 15 mm) were purchased
from Falcon Labware (Cherry Hill, New Jersey). Hamilton syringes were purchased
from VWR Scientific, Incorporated (Atlanta, Georgia). MG sera were generously
provided by Dr. Peter Dau (Evanston's Hospital, Evanston, Illinois), Dr. Paul Morand
(Children's Hospital, San Francisco, California) and by the DeKalb General Hospital
(Decatur, Georgia). MG plasmaand rabbit antiserum to Torpedo californica AcChR
were generously provided by Dr. Jon Lindstrom (The Salk Institute, San Diego,
California).
All solutions were prepared using deionized, double-distilled water. Stock
solutions of sodium chloride, disodium phosphate, monosodium phosphate, sodium
acetate and Tris-HCl were maintained at 4°. Solutions used in the isolation of
acetylcholine receptor were; sodium chloride, 100 mM; sodium phosphate buffer, 10
5
6
mM, pH 7.0; sodium azide, 10 mM; Triton X-100, 2% (v/v); Triton X-100, 0.5% (v/v).
Laboratory Animals
Male, 4-month old New Zealand rabbits weighing 5-6 lbs, were obtained from
the late Hiram Davis (Stockbridge, Georgia). They were maintained on Purina
Rabbit Chow and tap water ad libidum.
Preparation of Plates
Plates suitable for agar gel-diffusion studies were prepared as described by
Barnes et al.^® The medium was prepared by heating to 100° a 1% solution of
agarose in 0.85% saline solution, buffered with 100 mM sodium phosphate, pH 7.4.
Sodium azide (1% w/v) and glycin (0.75% w/v) were added to the medium as a
preservative and as a mositurizer, respectively. The hot agar solution was
poured in 5 ml aliquots into a petri dish (box type, 100 x 15 nm). After the agar
congealed and on cooling, holes were cut in a conventional pattern using a sterile
pasteur pipette 6 mm in diameter. A useful pattern (Fig. 1) consists of a central
hole with six circumferential holes spaced so that the distance from the edge of the
center hole to that of the periphereal holes is 1 cm. This is easily accomplished by
placing the dish over a pattern precisely drawn on white paper. The agar was
removed from the holes with a sterile probe.
The central wells of the plates were filled with various antisera as identified in
the text using a 25 pi Hamilton syringe and the peripheral wells were filled with
treated or untreated AcChR preparation. Plates were stored at 37° for three to
four days before they were examined for precipitin lines between antiserum and
antigen wells. Troublesome condensation was avoided by placing a tightly fitting
piece of filter paper within the lid of the petri dish.
7
Fig. 1. The conventional arrangement of the Ouchterlony plates. Wells 1-6
contain the antigen and the center well, residual antibody.
8
Preparation of Acetylcholine Receptor
The preparation of the AcChR protein from rabbit by detergent extraction is
23
described by Lindstrom. A flow chart representation of this procedure is outlined
in Fig. 2. Fresh or recently frozen rabbit calf and soleus muscles were homogenized
for 1 min in 4 vol of 0.1 M NaCl, 0.01 M sodium phosphate buffer, pH 7.4, and 0.01 M
NaN^ in an Osterizer Galaxie Blender at 4°, followed by centrifugation for 30 min at
10^ g. The supernatant fraction was discarded. The resulting pellet was
resuspended in 2 vol of the same buffer containing 2% (v/v) Triton X-100, followed
by gentle stirring at 4° for 1 hr. The ^mixture was centrifuged at 10^ g for 1 hr. The
supernatant solution which contained solubilized AcChR was decanted and the
sedimented pellet discarded. The supernatant solution was filtered through glass
wool to remove unwanted lipid. The filtered supernatant solution was diluted in
0.5% Triton buffer containing 0.01 M NaCl, 0.01 M sodium phosphate buffer, pH 7,0
and 0.01 M NaN^*
The solubilized AcChR protein was concentrated using the ultrafiltration
24
aparatus Fig. 3. Further purification was achieved by applying the concentrated
receptor solution to a 1.5 x 7.0 cm DEAE cellulose column, which had been
equilibrated with 0.01 M sodium phosphate at pH 6.8 (10 ml), 7.0 (10 ml) and 8.9 (40
ml). Sixty-five fractions (0.5 ml vol) were collected at a flow rate of 6 ml/hr.
Protein in each fraction was determined spectrophotometically at 280 nm. The
major protein fractions were pooled and pipetted into a dialysis tubing (1.0 x 15 cm)
and concentrated by dehydration with Sephadex G-200-120, which absorbs water
from aqueous samples. The concentrated receptor was then dialyzed overnight to
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Fig. 2. Flow chart for the purification of rabbit muscle acetylcholine
receptor.
h Diagram of ultrafiltration apparatus.
11
Immunodiffusion was performed on the rabbit AcChR with MG serum, normal serum
and rabbit antiserum to Torpedo californica AcChR. The center wells of the plates
were filled with AcChR and the peripheral wells filled with MG serum, normal serum
and rabbit antiserum to Torpedo californica in alternating sequences. The purified
receptor was subjected to periodate oxidation, proteolysis and/or lectin binding
experiments.
The carbohydrate concentration of the purified AcChR was determined by the
25method of Dubois ^ al. with glucose as the standard. The protein concentration
26
of AcChR was determined by the method of Lowery et with BSA as the
standard.
Periodate Oxidation of Acetylcholine Receptor
Periodate oxidation was used in an attempt to destroy the carbohydrate
component of the AcChR. Periodate oxidation is useful in structural studies of
carbohydrates because periodate selectively cleaves the bond between adjacent
carbon atoms that carry vicinal hydroxyls, carbonyls, and primary amines or mixed
27
combinations of these groups. The selectivity of the reaction arises from the
ability of periodate to form a cyclic intermediate with the vicinal groups thus
cleaving the carbon bond. The oxidation was performed as described by the modified
method of Spiro. The oxidation was carried out with AcChR (24 mg/ml) in 0.5 - 1.5
ml of 0.02 M sodium acetate, pH 6.0 and containing 0.08 M NalO^ for 20 hr at 25° in
the dark. The reaction was quenched by the addition of 100 pi ethylene glycol. The
samples were next subjected to hydrolysis in 2 N HCl atl00° for 3 hr to cleave the
12
glycosidic bonds. The hydrolysate was then neutralized with 0.1 M KOH. Two
controls were prepared and processed simultaneously under identical conditions as
above: the first control contained untreated AcChR and buffer without NalO^, and
the second contained NalO^ and buffer but no AcChR.
Aliquots of the neutralized hydrolysate were assayed for residual carbohydrate
by thin layer chromatography and spectrophometrically by the phenol-sulfuric acid
25
method of Dubois et al.
Proteolytic Cleavage of the Acetylcholine Receptor
Proteolysis was used in an attempt to degrade the protein component of the
AcChR. Proteinases present in crude or unpurified protein preparations often
catalyze the break-down of proteins by hydrolyzing the peptide bonds. The
effectiveness of different proteolytic enzymes was investigated by incubating
AcChR with pronase V, pronase VIII, pronase XI and pronase XIV for varying periods
of time at 37° at their pH optima of 7.5. Trypsin was incubated with AcChR (24
mg/ml) at 25° at the pH optimum of 7.6. Pronases V, VIII, XI and XIV were shown to
29
be active since they hydrolyzed the substrate. Trypsin was also shown to be active
29
since it hydrolyzed hemoglobin.
Pronase XIV proved to be the most effective proteolytic enzyme as shown in
Table 1 and was the enzyme of choice for further experiments. AcChR (24 mg/ml)
was incubated at 37° with pronase XIV (2 mg) in 1 m Tris-HCl buffer, pH 7.5.
Aliquots were removed at fixed time intervals (0, 10, 30, 60 min). The residual
protein was precipitated by the addition of 0.1 ml of a 5% solution of
Table 1 . The Effect of Proteinases on the Protein Content of the Acetylcholine Receptor.
OD
Time (min) Trypsin Pronase VIII Pronase XI Pronase XIV
0 0.218 ± 0.005 0.200 ± 0.001 0.220 ± 0.025 0.180 + 0.002
10 0.200 ± 0.001 0.190 ± 0.002 0.240 ± 0.020 0.120 + 0.005
30 0.193 ± 0.010 0.181 + 0.05 0.214 ± 0.001 0.092 + 0.009
60 0.160 + 0.003 0.153 ± 0.015 0.195 + 0.002 0.045 + 0.001
AcChR (24 mg/ml) was incubated at varying times with the above proteinases. Results are expressed as OD
readings for protein remaining after degradation.
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trichloroacetic acid (TCA). This also terminated the pronase activity. Each sample
was centrifuged in a Beckman Microfuge B and the supernatant solution was assayed
for protein by spectrophometric analysis of 280 nm. Thin layer and paper
chromatography were used to check for free sugars, amino acids, or small peptides
in the digested samples. Two controls were prepared and processed simultaneously
under identical conditions as above: the first control contained AcChR and buffer,
and the second contained pronase XIV and buffer.
Chromatographic Analysis of Digested Samples
of Free Sugars
The pronase digested AcChR was subjected to ascending paper chromoto-
graphy. A 1 pi aliquot was spotted on Eastman 13179 silica gel paper with D-
glucose, D-fructose, D-mannose, D-galactose, N-acetyl-D-glucosamine, N-acetyl-D-
galactosamine and N-acetyl-neuraminic acid as standards. The applied samples were
air dried and the chromatogram was developed in ethyl acetate, pyridine and water
(v/v 8:2:1) solvent system for 90 min. The chromatograms were air-dried and
sprayed with triphenyl tetrazolium chloride. Chromatographic analyses were also
performed on the digested samples using Whatman No. 3 paper (46 x 57 cm) and the
same solvent system for 16 hr to determine which paper gave the better resolution.
The Eastman 13179 Silica gel paper was found to give better resolution.
Serological (AcChR-Antibody) Titer of Myasthenia Gravis Serum
30
Antibody titer was detected as described by Benson. Antibody was diluted
with normal serum 1:10. A serial dilution of the antibody preparation was made.
15
The first tube contained a 1:10 dilution of serum and 6 consecutive 50% dilutions
were made. The highest dilution was, therefore, 1:640. Tube #8 contained buffered
saline alone. To each tube containing 0.5 ml of each dilution or saline was added 0.5
ml AcChR. The mixtures were incubated for 30 min at 37° in a water bath with
constant agitation and the aggregates were removed by centrifugation for 7 min at
350 g. Agglutination was determined by noting the turbidity produced by gently
tapping the tubes after centrifugation. This is the classical serological test for the
titer of an antibody.
Lectin Binding to Acetylcholine Receptor
Various plant lectins were used in an attempt to modify the carbohydrate
components of the AcChR. Lectins are highly specific, polyvalent, carbohydrates
29
binding proteins. These properties make them useful in studies on polysac¬
charides, glycoprotein, cell membrane enzyme tagging, cell agglutination and cell
29
typing. The binding of plant lectins to AcChR was performed as described by the
31
modified method of Winnacott. AcChR was incubated with Con A, wheat germ,
garden pea and soybean lectins for 30 min at 22° respectively. These lectins were
tried to determine which was most effective in binding to the AcChR. According to
31
Winnacott, et al. Con A binds D-glucose and D-mannose residues with a high
degree of selectivity, whereas soyobean lectin binds D-galactose and N-acetyl-D-
galactosamine. The AcChR must have a large number of D-glucose and/or D-
mannose residues available for Con A binding since Con A bound AcChR better than
any of the other lectins tried. The system for Con A binding to AcChR is described
below.
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Increasing concentrations of Con A were added to a series of centrifuge tubes
containing 3.6 mg/ml AcChR. A flow chart representation of this procedure is
outlined in Fig. U. The mixtures were incubated for 30 min at 22°, then centrifuged
in a Beckman Microfuge B. An aliquot volume of each mixture was further
incubated for 5 min at 22° with untreated MG serum. The antibody-Con A-AcChR
complex was removed by centrifugation in a Beckman Microfuge B. The supernatant
from this centrifugation contained residual antibodies for carbohydrate and will be
referred to as'CH20*AcChRr AbRj^'. Two controls were prepared and processed
simultaneously and under identical conditions as above; the first control contained
AcChR and buffer and the second contained Con A and buffer.
Binding of Con A to Pronase-Treated
Acetylcholine Receptor
Earlier studies found that pronase XIV was useful in producing a partially
degraded AcChR. Partially degraded AcChR was produced by pronase treatment,
and used in a subsequent experiment where it was incubated with Con A. AcChR
(3.6 mg/ml) was incubated with 2.0 mg pronase XIV for 30 min at 37°. The pronase
activity was terminated and protein precipitated by addition of 5% TCA as described
previously. The supernatant solution, was dialyzed against water overnight at 4°.
The protein content of the dialyzed sample was determined spectrophotometrically
as described previously. Two controls were prepared and processed simultaneously
under identical conditions as above; one control contained AcChR and buffer, and








































Fig. 4. Flow chart for the preparation of residual antibody ('CHgO•AcChR-AbR^').
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The digested samples referred to as Pronase-treated AcChR' were analyzed
for Con A binding. Increasing concentrations of Con A were added to a series of
centrifuge tubes containing 3.6 mg/ml Pronase-treated AcChR'. The mixtures were
incubated for 30 min at 22°, then centrifuged for 4 min at 13,400 rpm in a Beckman
Microfuge B. The supernatant solution contained carbohydrate and partially
digested protein. This supernatant solution is referred to as Pronase-treated
AcChR-Con A complex.'
Affinity Chromatography of the Acetylcholine Receptor
Con A-Sepharose 4B resin was used as the stationary phase in affinity
chromatography for binding of AcChR. A flow chart representation of this
procedure is outlined in Fig. 5. A 0.6 x 14.6 cm column was packed with resin to a
height of 3 cm. AcChR (12 mg/ml) was applied to the column. The column was
washed once with 1 ml of 0.01 M sodium acetate buffer, pH 6.0, to remove any
unbound receptor. A 100 pi aliquot of untreated myasthenic serum was placed on
the top of the resin in the column and allowed to enter the resin very slowly. After
the serum had completely entered the resin, 1.0 ml of acetate buffer was slowly
introduced at the top of the column and eluent collection begun until the acetate
buffer had completely entered the resin. A second 1.5 ml of acetate buffer was
-allowed to pass through the column. This washing procedure was used to remove
unbound serum for the column. The first 0.8 ml of eluent from this procedure
contained most of the serum protein applied to the column and is referred to as
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Fig. 5. Flow chart for residual fractions from affinity column chromatography.
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described previously. AcChR was applied to a column containing Sepharose 4B but
without Con A and the unbound antibody eluted with 1.0 ml of 0.01 M sodium
acetate buffer, pH 6.0. This unbound antibody fraction referred to as 'Control
CH20*AcChR«AbR2, was collected and concentrated as described previously.
■Pronase-treated AcChR' (3.6 mg/ml) was applied to a Con A-Sepharose 4B column.
This column was washed once with 1.0 ml of 0.01 M sodium acetate buffer, pH 6.0 to
remove unbound receptor. A 100 yl aliquot of untreated myasthenic serum was then
applied to the column. The column was washed with 1.0 ml acetate buffer as above
to remove any unbound antibody in the resin. This eluted fraction of unbound
antibody is referred to as 'Ch20 AcChR AbR^'. The collected 'CH20*AcChR‘’AbR2'
was concentrated by ultrafiltration. 'Pronase-treated AcChR' was applied to a
column containing Sepharose 4B but without Con A and the unbound antibody eluted
with 1.0 ml of 0.01 M sodium acetate buffer, pH 6.0. This unbound antibody
fraction, referred to as 'Control CH20*AcChR®AbR2', was collected and concentrat¬
ed by ultrafiltration. All of the unbound antibody fractions were evaluted by
immunodiffusion for their specificity toward the carbohydrate and/or protein in the
AcChR, 'AcChR-Con A complex', 'Pronase-treated AcChR' and 'Pronase-treated
AcChR-Con A complex'.
RESULTS AND DISCUSSION
Receptor Purification and Isolation
The yield of the AcChR from rabbit was 4.8 mg receptor/g wet weight of
tissue. The receptor contains 0.023 yg carbohydrate/mg receptor protein. The
purification of the AcChR from rabbit muscle was carried out according to the
23
procedure of Lindstrom for human muscles which was a modification of his
original procedure for purification of the AcChR from Torpedo californica. The
purification of AcChR was evaluated by; (1) the characteristic eiution pattern from
the DEAE-cellulose column and (2) the formation of precipitin bands between
AcChR and MG serum or rabbit antiserum to Torpedo caiifornica, but not with
normal human or rabbit serum.
The purification of AcChR was carried up to the DEAE celluiose chromato¬
graphy step and evaluated as stated below. Fractions 56 to 63 which formed a single
symmetrical peak as shown in the elution pattern in Figs. 6a and 6b, were pooled and
gave a single elution peak from DEAE cellulose chromatography. This product was
evaluated for antigenicity using immunodiffusion, Fig. 7. Immunodiffusion precipitin
tests of the eluted rabbit AcChR were performed against normal human serum,
rabbit serum, MG serum and rabbit antiserum to Torpedo californica AcChR, as in
the Experimental Section. The data presented here suggests cross-reactivity
between rabbit AcChR and MG serum or rabbit antiserum to Torpedo californica
AcChR, but not with normal serum as illustrated in Fig. 7. These findings indicate
that the AcChR was indeed isolated and no further purification was attempted.
21
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Fig. 6b. Elution pattern of fractions 56 to 63 from DEAE cellulose column.
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7. Agar gel-diffusion pattern of AcChR against MG serum, normal sera and
rabbit antiserum to Torpedo caiifornica AcChR. Center well contains purified
AcChR for rabbit; wells 1 and 4, rabbit antiserum to Torpedo caiifornica AcChR;
wells 2 and 5, normal serum; and wells 3 and 6, MG serum.
25
Antibody - Antigen Agglutination
Tube agglutination tests were used to determine the serologic titer of aggluti¬
nating antibodies present in myasthenic serum. If, for example, agglutination occurs
with MG serum at 160 fold dilution, this was interpreted as a titer of 160 for that
patient's serum. Such titrations were used to determine the level of antibody
reactive against AcChR present in myasthenic serum.
To study the antigentic roles of both the carbohydrate and protein moieties of
the AcChR, the AcChR was subjected to chemicai modifications as outlined in the
Experimental procedure. The appr-opriate concentrations of the carbohydrate
25
remaining after periodate oxidation (according to the phenol-sulfuric acid method)
are summarized in Table 2. Control samples carried through the procedure without
NalO^ showed no change in the carbohydrate content. Destruction of carbohydrate
has been achieved by others with a 2000/1 ratio of periodate to glycoprotein which
resulted in almost total oxidation of carbohydrate. This excess ratio was not used
because the preliminary results indicated a 15% destruction, which was presumed to
be sufficient to determine the antigenicity of the carbohydrate portion of the
receptor. Even though periodate treatment of AcChR identified loss of activity by
partial destruction of carbohydrate, this did not give the answer to the question of
antigenicity of the carbohydrate. However, previous investigators who had studied
the possible involvement of carbohydrate in the antigenticity of Torpedo californica
AcChR found that periodate treatment designed to destroy or to remove
carbohydrate failed to diminish the antigenicity of the receptor as judged by
31
radiommunassay. These findings suggested a second approach in which the
antigenicity of the carbohydrate could be determined.




Periodate (mM) 0 min 20 hr
26.7 0.249 ± 0.002 0.270 ± 0.001
40.0 0.343 + 0.005 0.397 ± 0.001
4S.0 0.395 ± 0.010 0.399 ± 0.003
AcChR (24 mg/ml) was incubated at 25° for 20 hr in the dark with NalO^ at pH 6.0. The oxidation was
terminated by addition of ethylene glycol followed by hydrolysis and neutralization.
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In this approach the AcChR was treated with five proteinases with the results
as presented in Table 1. There was slight (0-25%) degradation of the receptor
protein with pronase VIII, XI and trypsin. This indicated that the AcChR was not
digestible to any significant degree by the three enzymes. Proteolysis with pronase
V was completed but the hydrolysis product was not used when it was discovered
that the pronase V preparation was contaminated with significant amounts of
carbohydrate. Pronase XIV treatment resulted in 70-80% proteolysis of the receptor
protein after 1 hr. With the partial proteolytic degradation of AcChR it was
possible that the carbohydrate moeity remained sufficiently intact so that its
antigenicity could be evaluated.
Proteins and carbohydrates were identified by spectrophotometry and by the
phenol-sulfuric test respectively, but no mono- or oligosaccharides were detected by
paper or thin layer chromatography, although some carbohydrates were detected
very close to the origin. This suggested that the carbohydrate moiety was left
relatively intact or was at least not severely damaged by proteolysis. Some free
amino acids were detected by paper chromatography, but the bulk of the original
protein moiety of rabbit AcChR remained close to the origin, at loci overlapping
those occupied by carbohydrate. It was presumed, therefore, that carbohydrate was
still attached to the residual protein. If proteolysis has destroyed the native protein
structure and probably it's contributions to antigenicity of the AcChR, the
antigencity of the carbohydrate could still be explored.
Since periodate oxidation at the level used failed to cause an apparent
decrease in carbohydrate, and since partial degradation of AcChR was achieved
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using pronase XIV, the latter was used in conjunction with other procedures to
determine the antigenicity of the carbohydrate and protein portions of the AcChR.
Binding of Acetylcholine Receptor by Plant Lectin
The reactivity of Con A with AcChR has been reported for AcChR isolated
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from the Torpedo californica and eel. Several lectins (soybeans, garden pea,
wheat germ and Con A) were, therefore, evaluated for their ability to bind to the
AcChR preparation. Soybean, garden pea and wheat germ lectins did not react with
the AcChR, although the wheat germ lectin reacted with MG serum. Only Con A
reacted with the AcChR with no reactivity toward MG serum. The binding of
AcChR to Con A is illustrated in Fig. 4. The Con A-AcChR complex formed a
precipitin line with MG serum. The absence of spurring in this test was indicative of
immunologic identity between 'Con A-AcChR complex' and untreated AcChR (Fig.
8). Fig. 8 also indicates that MG serum reacts mildly with 'Pronase-treated AcChR'.
The supernatant from the reaction of the 'Con A-AcChR complex' and MG serum
CCH2OAcChR‘AbRj^') was investigated for immunoreactivity to AcChR, 'Con A-
AcChR complex', 'Pronase-treated AcChR', and 'Pronase-treated AcChR Con A
complex'. The 'CH2O‘AcChR‘Abj' formed a precipitin line with AcChR but not with
the 'Con A-AcChR complex'. Fig. 9. The 'CH2O AcchR AbRj^' reacts also with 'Pro¬
nase-treated AcChR' but not with 'Pronase-treated AcChR-Con A' complex Figs. 10
and 9, re^ectively. These findings, which are summarized in Table 3, indicate that
antigenicity resides in both the carbohydrate and protein portions of the AcChR.
Column chromatography was used to evaluate further the effectiveness of Con
A binding to the intact receptor. In this assay, purified, solubilized AcChR was
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Fig. 8. Agar gel-diffusion pattern of untreated MG serum against AcChR, Con A or
pronase buffer, and 'Con A-AcChR complex' or 'pronase-treated AcChR'. Center
well contains untreated-MG serum; wells 1 and 4 AcChR; wells 2 and 5, Con A or
pronase buffer; and wells 3 and 6, 'Con A-AcChR complex' or 'Pronase-treated
AcChR'.
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Fig. 9. Agar gel-diffusion pattern of residual antibody 'CH2O AcChR AbR ' against
AcChR, Con A buffer and 'Con A-AcChR complex' or pronose treated AcCnR-Con A
complex. Center well contains CH2O AcChR AbR^; wells 1 and AcChR; wells 2
and 5, Con A buffer; and wells 3 and 6, Con A-AcChR complex; or pronase treated
AcChR-Con A complex.
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Fig. 10. Agar gel-diffusion pattern of residual antibody 'CH2O AcChR AbRj^' against
AcChR, pronase buffer and 'pronase-treated AcChR'. Center well contains
'CH2O AcChR AbRj'; wells 1 and AcChR; wells 2 and 5, Con A buffer or pronase
buffer; and wells 3 and 6, 'pronase-treated AcChR'.
Table 3. A Comparison of Immunodiffusion Results for Untreated MG Serum and the Residual Antibody
Present in MG Serum after Precipitation with 'Con A-AcChR Complex' ('CH20*AcChR*AbR^').
MG Serum MG Serum
Sample Normal Serum (Untreated)^ (CH20-AcChR-AbRj)*’










The untreated MG serum was whole MG serum; Ch20*AcChR»AbRj was the supernatant from the reaction
of MG serum with the Con A-receptor complex.
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exposed to Con A-Sepharose 4B beads. AcChR reacted with the Con A via the
carbohydrate moiety. The column was then washed free of unbound AcChR.
Antiserum containing antibody to the AcChR was then passed through the column in
suboptimum amounts based on the titer of that serum (for example, 3.6 mg/ml
AcChR for 1:160 titer). The antibody would be expected to bind to the protein
protion of the AcChR and if there were any antibody molecules to carbohydrate,
they would not be expected to bind if the carbohydrate were masked by the bound
Con A. The effluent solution potentiaily containing antibody to the carbohydrate
moiety of AcChR was tested for immunoreactivity against AcChR, 'Con A-AcChR
complex', 'Pronase-treated AcChR', 'Pronase-treated AcChR Con A complex' and
'Con A AcChR-pronase-treated complex'. These results were comparable to those
obtained using free Con A. The'CH20*AcChR®AbR2', the unbound serum fraction re¬
sulting from passage of whole serum through a column containing Sepharose 4B-Con
A-AcChR complex, formed a precipitin line with untreated AcChR but not with the
'Con A-AcChR complex' (Fig. 11). Fig. 12 indicates that 'CH20*AcChR*AbR2'
reacted with 'Pronase-treated AcChR', however Ch20 AcChR AbR2' did not react
with Pronase-treated Con A-AcChR complex' or 'Con A-AcChR pronase complex'
(Fig. 11). The 'CH20®AcChR*AbR2' serum fraction resulting from passage of whole
serum through a column containing Sepharose 4B formed a precipitin line with both
'AcChR and Con A-AcChR complex' (Fig. 13). Fig. 13 also indicates that the
'Control CH20«AcChR*AbR2' reacts with'Pronase-treated AcChR'. The'CH20*
AcChR'AbRy, the unbound serum fraction resulting from passage of whole serum
through a column containing Sepharose 4B-'Con A-pronase-treated AcChR', formed a
precipitin line with AcChR and 'Con A-AcChR complex' (Fig. 12). Fig. 12 also
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Fig. 11. Agar gel-diffusion pattern of residual antibody 'CH2O AcChR AbR2' against
AcChR, Con A or pronase buffer and 'Con A-AcChR complex or 'Con A-pronase
treated AcChR complex'. Center well contains 'CH2O AcChR AbR2'; wells 1 and 4,
AcChR; wells 2 and 5, Con A or pronase buffer; and wells 3 and 6, 'Con A-AcChR
complex' or 'Con A pronase-treated AcChR complex'.
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Fig. 12. Agar gel-diffusion pattern of residual antibody 'CH2O AcChR AbR2' or
'CH2O AcChR AbRy against AcChR, Con A or pronase buffer and 'Con A-AcChR
complex' or 'pronase-treated AcChR complex'. Center well contains
'CH2O AcChR AbR^' or 'CH2O AcChR AbR^'; wells 1 and 4, AcChR; wells 2 and 5,
Con A or pronase buffer; wells 3 and 6, 'pronase-treated AcChR'.
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Fig. 13. Agar gel-diffusion pattern of 'Control CH2O AcChR AbR2' or
'CH2O AcChR AbR^' against AcChR, Con A or pronase buffer and Con A-AcChR
complex or 'pronase-treated AcChR'. Center well contains 'Control
CH2O AcChR AbR2' or 'CH2O AcChR AbRy wells 1 and 4, AcChR; wells 2 and 5,
Con A or pronase buffer; and wells 3 and 6, 'Con A-AcChR complex' or 'pronase-
treated AcChR'.
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indicates that the 'CH20*AcChR*AbR2' reacted with "Pronase-treated AcChR'. The
'Control CH20»AcChR*AbRj', the serum fraction resulting from passage of whoie
serum through a column containing Sepharose 4B-'Pronase-treated AcChR', formed a
precipitin line with AcChR, 'Con A-AcChR complex' and 'Pronase-treated AcChR'
(Fig. 13). No precipitin line was formed using the various residual antisera with
•Pronase-treated AcChR-Con A complex' or with 'Con A-pronase-treated AcChR
complex'. These findings which are summarized in Table 4 lend further support to
the thesis that antigenicity resides in both the carbohydrate and protein components
of the AcChR.
Although difficult to photograph, it is important to note that in many of our
plates double precipitin iines were seen for reaction between untreated AcChR and
MG serum. Fig. 7. On most occasions, however, the precipitin lines were merged to
present what appeared to be a single band.
Table 4. A Comparison of Results of Immunodiffusion Precipitin Test of Residual Antibody Obtained by
Three Different Precipitation Systems.
MG Serum
MG Serum
MG Serum Control MG Serum
Sample (untreated)^ 'CH20*AcChR*AbR2'*^ 'CH20«AcChR-AbR2^3'^ 'CH20*AcChR*AbR3'^
AcChR + + + + + + + + + + + +
















The untreated MG serum was whole MG serum; the unbound serum fraction resulting from passage of
whole MG serum through a column containing Sepharose 4B-Con A-AcChR complex; She serum fraction
resulting from passage of wholg MG serum through a column containing Sepharose 4B AcChR or Sepharose
4B "Pronase-treated AcChR'; °the unbound serum fraction resulting from passage of whole MG serum
through a column containing Sepharose 4B-Con A-pronase-treated AcChR.
CONCLUSIONS
The data from the sensitive and convenient techniques of portoelysis, Con A
binding, affinity chromatography and immunoprecipitation supported the earlier
findings that antigenicity resides in the protein moiety, and presented new evidence
to suggest that the CH2O moiety of the AcChR is also antigenic. It is important to
note, however, that the purification of AcChR was carried up to the DEAE cellulose
chromatography step and that further purification of the AcChR by an affinity
column consisting of a-bungarotoxin from Bungarus multicinctus coupled to agarose
is needed in the future.
Further studies on the acetylcholine receptor are needed in order to
determine: (a) the composition of the carbohydrate moiety, (b) the haptenic
grouping that may reside in the carbohydrate portion of the AcChR, (c) whether
such carbohydrate haptenic groups could be mass-produced (synthesized) in the
laboratory and used effectively in the control of MG, (3) whether Con A-treated
rabbit muscle AcChR could elicit an immune response in a guinea pig, and also if the
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Ouchterlony Gel Diffusion Test
The technique of double diffusion in two dimensions was developed indepen-
dently by Elek and Ouchterlony. This technique is particularly useful for the
study of complicated antigen-antibody systems because of its high resolving power
and the ease with which one system can be compared with another. When antigen
and antibody are in reservoirs of identical size and shape, the curvature of the
precipitin line depends in part on the relative molecular weight of antigen and
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antibody. If both are of the same molecular weight, the line is usually straight,
otherwise the line tends to be concave toward the reagent of higher molecular
weight.^^
Ouchterlony distinguished three principal types of reaction that may be
observed when related antigens in adjacent wells react with antibodies against the
various antigenic determinants diffusing from a central reservoir (Fig. 14). Type I,
the so-called reaction of identity, is characterized by fusion of bands of precipitate.
In Type II, the reaction of nonidentity, the precipitin lines intersect, or cross, be¬
cause the samples do not contain an identical antigenic determinant. Type III is the
reaction obtained when the two antigens being compared possess common determi¬
nants but the preparations also display antigenic differences. This is demonstrated
in Fig. 14c where it is seen that the antibody reacts strongly with antigen AB, but
not as strongly with antigen A. The shape of the interacting precipitin lines shows
continuity and spurring indicative of antigenic similarity and difference, respective¬
ly. This occurs because the antibody preparation diffuses towards antigens AB and A
and reacts with the A component to produce a line of precipitation showing the
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reaction of identity. Antibody B, however, diffuses through the A-anti-A precipitate
and forms a precipitate with antigen B. Most of this is in the same band as the A-
anti-A precipitate, but a little extends beyond as a spur. Double spur formation
(Fig. 14d) occurs when each of the cross-reacting antigens is somewhat different
from the antigen used to produce the antiserum. The use of the word "identity" has
been criticized because the method offers only evidence that two antigenic
components produce a single, visible precipitate with the same antiserum. They





a. Type I - Identity
AB A
c. Type III - Partial Identity
A B
anti-A,B
b. Type II - Nonidentity
AB BC
anti-A,B,C
d. Type IV - Partial Identity
Fig. 14. Types of reactions in Ouchterlony gel diffusion precipitation tests. A, B,
and C represent determinant groups on cross-reacting antigen molecules, which are
placed in neighboring wells, equidistant from a well containing antiserum (anti-A,
anti-A,B, etc.).
